XML 32 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:    
Net loss $ (32,070) $ (464,030)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation, depletion and amortization 28,068 40,268
Impairment expense 0 476,936
Loss (gain) on derivative instruments 142,223 (56,628)
Cash settlements (paid) received on expired derivative instruments (90,214) 61,135
Cash settlements received on terminated derivative instruments 0 17,977
Bad debt expense 95 294
Amortization and write-off of deferred financing costs 626 3,272
Gain on extinguishment of debt (5,516) 0
Accretion of asset retirement obligations 6,611 6,206
Share-based compensation (see Note 11) 1,047 (112)
Settlement of asset retirement obligations (296) (327)
Changes in operating assets and liabilities:    
Accounts receivable (61,172) 1,950
Prepaid expenses and other assets 296 (2,334)
Payables and accrued liabilities 73,655 (9,803)
Other (384) (474)
Net cash provided by operating activities 62,969 74,330
Cash flows from investing activities:    
Additions to oil and gas properties (29,294) (34,833)
Additions to other property and equipment (539) (1,057)
Additions to restricted investments 1 0
Other 404 0
Net cash used in investing activities (29,428) (35,890)
Cash flows from financing activities:    
Advances on revolving credit facility 0 25,000
Payments on revolving credit facility (25,000) (55,000)
Proceeds from the paycheck protection program 0 5,516
Deferred financing costs (25) (115)
Dividends to stockholders 0 (3,786)
Shares withheld for taxes (81) (51)
Other 0 35
Net cash used in financing activities (25,106) (28,401)
Net change in cash and cash equivalents 8,435 10,039
Cash and cash equivalents, beginning of period 10,364 325
Cash and cash equivalents, end of period $ 18,799 $ 10,364